APO Research
Talk to an analyst

APO RESEARCH · REPORT

23-Valent Pneumococcal Polysaccharide Vaccine

23-Valent Pneumococcal Polysaccharide Vaccine is a vaccine product category defined by its pneumococcal antigen composition and formulation.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.

23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.

Antigen composition, conjugation status, presentation and labelled indications distinguish supplied vaccines. Products with different compositions are not interchangeable solely because a headline count is similar.

The commercial boundary

The selected edition describes a market scope. Product approvals, labelled use and clinical acceptance require their own evidence; neither report segmentation nor an illustrative image establishes medical suitability.

Which antigen composition and formulation define the vaccine?

Antigen composition, conjugation status, presentation and labelled indications distinguish supplied vaccines. Products with different compositions are not interchangeable solely because a headline count is similar.

Selected research

Industry Growth & Trends

Global 23-Valent Pneumococcal Polysaccharide Vaccine Industry Growth and Trends Forecast to 2032

2 January 202672 pages

Choose your research edition.

Industry Research23-Valent Pneumococcal Polysaccharide Vaccine Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal 23-Valent Pneumococcal Polysaccharide Vaccine Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal 23-Valent Pneumococcal Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032172 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal 23-Valent Pneumococcal Polysaccharide Vaccine Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal 23-Valent Pneumococcal Polysaccharide Vaccine Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

23-Valent Pneumococcal Polysaccharide Vaccine is a kind of vaccine used to prevent infection caused by pneumococcal bacteria. 23-Valent Pneumococcal Polysaccharide Vaccine contains 23 of the most common types of pneumococcal bacteria.

23-Valent Pneumococcal Polysaccharide Vaccine is for use only in adults and children who are at least 2 years old. For children younger than 2 years old, another vaccine called Prevnar (pneumococcal conjugate vaccine [PCV] 7-valent) is used, usually given between the ages of 2 months and 15 months.

The major players in global 23-Valent Pneumococcal Polysaccharide Vaccine market include MSD, Sanofipasteur, etc. The top 2 players occupy about 80% shares of the global market. North America and Europe are main markets, they occupy about 50% of the global market. Single Dose Vial is the main type, with a share about 60%. For Children (2-10) is the main application, which holds a share about 40%.

Read the full market overview

Report Scope

This report provides a structured, data-driven view of the global 23-Valent Pneumococcal Polysaccharide Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The 23-Valent Pneumococcal Polysaccharide Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Dose) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global 23-Valent Pneumococcal Polysaccharide Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to 23-Valent Pneumococcal Polysaccharide Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global 23-Valent Pneumococcal Polysaccharide Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

23-Valent Pneumococcal Polysaccharide Vaccine Market by Company

MSD

Sanofipasteur

CDIBP

23-Valent Pneumococcal Polysaccharide Vaccine Segment by Type

Single Dose Vial

Pre-filled Syringe

23-Valent Pneumococcal Polysaccharide Vaccine Segment by Application

For Children (2-10)

For Person (10-64)

For The Old (Above or equal to 65)

23-Valent Pneumococcal Polysaccharide Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global 23-Valent Pneumococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of 23-Valent Pneumococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of 23-Valent Pneumococcal Polysaccharide Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of 23-Valent Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of 23-Valent Pneumococcal Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Single Dose Vial Table 2. Major Company of Pre-filled Syringe Table 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Dose) Table 5. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type (2021-2026) Table 6. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 7. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type (2021-2026) Table 8. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2021-2026) & (US$/Dose) Table 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (K Dose) Table 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type (2027-2032) Table 11. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2027-2032) & (US$ Million) Table 12. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type (2027-2032) Table 13. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Type (2027-2032) & (US$/Dose) Table 14. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Dose) Table 15. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Dose) Table 17. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Dose) Table 19. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Dose) Table 21. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (K Dose) Table 23. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2026) & (US$ Million) Table 24. 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends Table 25. 23-Valent Pneumococcal Polysaccharide Vaccine Industry Drivers Table 26. 23-Valent Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges Table 27. 23-Valent Pneumococcal Polysaccharide Vaccine Industry Restraints Table 28. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Revenue Market Share by Company (2021-2026) Table 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Company (2021-2026) & (K Dose) Table 31. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Company (2021-2026) Table 32. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Price by Company (2021-2026) & (US$/Dose) Table 33. Global 23-Valent Pneumococcal Polysaccharide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global 23-Valent Pneumococcal Polysaccharide Vaccine Major Company Production Sites and Headquarters Table 35. Global 23-Valent Pneumococcal Polysaccharide Vaccine Company, Product Type & Application Table 36. Global 23-Valent Pneumococcal Polysaccharide Vaccine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global 23-Valent Pneumococcal Polysaccharide Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (K Dose) Table 41. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Region (2021-2026) Table 42. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026) & (US$ Million) Table 43. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Region (2021-2026) Table 44. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 45. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2027-2032) & (K Dose) Table 46. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Region (2027-2032) Table 47. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Region (2027-2032) & (US$ Million) Table 48. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Region (2027-2032) Table 49. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Value (US$ Million), Price (US$/Dose) and Gross Margin (2027-2032) Table 50. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Dose) Table 52. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application (2021-2026) Table 53. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 54. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application (2021-2026) Table 55. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2021-2026) & (US$/Dose) Table 56. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (K Dose) Table 57. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application (2027-2032) Table 58. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2027-2032) & (US$ Million) Table 59. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application (2027-2032) Table 60. Global 23-Valent Pneumococcal Polysaccharide Vaccine Price by Application (2027-2032) & (US$/Dose) Table 61. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Dose) Table 62. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Dose) Table 64. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Dose) Table 66. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Dose) Table 68. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (K Dose) Table 70. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2026) & (US$ Million) Table 71. MSD Company Information Table 72. MSD Business Overview Table 73. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 74. MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio Table 75. MSD Recent Development Table 76. Sanofipasteur Company Information Table 77. Sanofipasteur Business Overview Table 78. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 79. Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio Table 80. Sanofipasteur Recent Development Table 81. CDIBP Company Information Table 82. CDIBP Business Overview Table 83. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2021-2026) Table 84. CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio Table 85. CDIBP Recent Development Table 86. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 87. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Dose) Table 88. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 89. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Dose) Table 90. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 91. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 92. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 93. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 94. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 95. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 96. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 97. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Dose) Table 98. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 99. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Dose) Table 100. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 101. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 102. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 103. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 104. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 105. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 106. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 107. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Dose) Table 108. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 109. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Dose) Table 110. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 111. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 112. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 113. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 114. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 115. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 116. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 117. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Dose) Table 118. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 119. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Dose) Table 120. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 121. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 122. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 123. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 124. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 125. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 126. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (K Dose): 2021 VS 2025 VS 2032 Table 127. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026) & (K Dose) Table 128. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share by Country (2021-2026) Table 129. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032) & (K Dose) Table 130. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share Forecast by Country (2027-2032) Table 131. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 132. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 133. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Country (2021-2026) Table 134. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 135. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Share Forecast by Country (2027-2032) Table 136. Key Raw Materials Table 137. Raw Materials Key Suppliers Table 138. 23-Valent Pneumococcal Polysaccharide Vaccine Distributors List Table 139. 23-Valent Pneumococcal Polysaccharide Vaccine Customers List Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. 23-Valent Pneumococcal Polysaccharide Vaccine Image Figure 2. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (2021-2032) & (K Dose) Figure 5. Single Dose Vial Image Figure 6. Global Single Dose Vial Sales YoY Growth (2021-2032) & (K Dose) Figure 7. Pre-filled Syringe Image Figure 8. Global Pre-filled Syringe Sales YoY Growth (2021-2032) & (K Dose) Figure 9. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Type 2025 VS 2032 Figure 11. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 12. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 13. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 23-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. For Children (2-10) Image Figure 24. Global For Children (2-10) Sales YoY Growth (2021-2032) & (K Dose) Figure 25. For Person (10-64) Image Figure 26. Global For Person (10-64) Sales YoY Growth (2021-2032) & (K Dose) Figure 27. For The Old (Above or equal to 65) Image Figure 28. Global For The Old (Above or equal to 65) Sales YoY Growth (2021-2032) & (K Dose) Figure 29. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Application 2025 VS 2032 Figure 31. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 32. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 33. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Market Share in Value by Application in 2025 Figure 41. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 42. North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 46. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 50. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 54. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Dose) Figure 58. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. 23-Valent Pneumococcal Polysaccharide Vaccine Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. 23-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • Single Dose Vial
  • Pre-filled Syringe
Applications
  • For Children (2-10)
  • For Person (10-64)
  • For The Old (Above or equal to 65)
Companies covered
  • MSD
  • Sanofipasteur
  • CDIBP

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 23-Valent Pneumococcal Polysaccharide Vaccine Market by Type
  6. 1.3.1 Single Dose Vial
  7. 1.3.2 Pre-filled Syringe
  8. 1.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Type
  9. 1.4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 23-Valent Pneumococcal Polysaccharide Vaccine Industry Trends
  2. 2.2 23-Valent Pneumococcal Polysaccharide Vaccine Industry Drivers
  3. 2.3 23-Valent Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges
  4. 2.4 23-Valent Pneumococcal Polysaccharide Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by 23-Valent Pneumococcal Polysaccharide Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by 23-Valent Pneumococcal Polysaccharide Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by 23-Valent Pneumococcal Polysaccharide Vaccine Price (2021-2026)
  4. 3.4 Global 23-Valent Pneumococcal Polysaccharide Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global 23-Valent Pneumococcal Polysaccharide Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global 23-Valent Pneumococcal Polysaccharide Vaccine Company, Product Type & Application
  7. 3.7 Global 23-Valent Pneumococcal Polysaccharide Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 23-Valent Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 23-Valent Pneumococcal Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
4 23-Valent Pneumococcal Polysaccharide Vaccine Regional Status and Outlook
  1. 4.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Size by Region
  3. 4.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 23-Valent Pneumococcal Polysaccharide Vaccine by Application
  1. 5.1 23-Valent Pneumococcal Polysaccharide Vaccine Market by Application
  2. 5.1.1 For Children (2-10)
  3. 5.1.2 For Person (10-64)
  4. 5.1.3 For The Old (Above or equal to 65)
  5. 5.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Application
  6. 5.2.1 Global 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global 23-Valent Pneumococcal Polysaccharide Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global 23-Valent Pneumococcal Polysaccharide Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 MSD
  2. 6.1.1 MSD Company Information
  3. 6.1.2 MSD Business Overview
  4. 6.1.3 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 MSD 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
  6. 6.1.5 MSD Recent Developments
  7. 6.2 Sanofipasteur
  8. 6.2.1 Sanofipasteur Company Information
  9. 6.2.2 Sanofipasteur Business Overview
  10. 6.2.3 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofipasteur 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
  12. 6.2.5 Sanofipasteur Recent Developments
  13. 6.3 CDIBP
  14. 6.3.1 CDIBP Company Information
  15. 6.3.2 CDIBP Business Overview
  16. 6.3.3 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 CDIBP 23-Valent Pneumococcal Polysaccharide Vaccine Product Portfolio
  18. 6.3.5 CDIBP Recent Developments
7 North America by Country
  1. 7.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
  2. 7.1.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
  6. 7.2.1 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
  2. 8.1.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
  6. 8.2.1 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
  2. 10.1.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
  6. 10.2.1 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa 23-Valent Pneumococcal Polysaccharide Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 23-Valent Pneumococcal Polysaccharide Vaccine Value Chain Analysis
  2. 12.1.1 23-Valent Pneumococcal Polysaccharide Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 23-Valent Pneumococcal Polysaccharide Vaccine Production Mode & Process
  7. 12.2 23-Valent Pneumococcal Polysaccharide Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 23-Valent Pneumococcal Polysaccharide Vaccine Distributors
  10. 12.2.3 23-Valent Pneumococcal Polysaccharide Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst